June was a challenging month for Novo Nordisk regarding cybersecurity and intellectual property protection. The pharma giant allegedly had some of its data — including intellectual property — stolen by two independent groups of threat actors. Unaware of each other, each group claimed to have acquired a large amount of valuable information. One demanded $25... Source
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.